Earnings Preview

CPA.DE Colgate-Palmolive Earnings Preview May 1, 2026

April 30, 2026
5 min read

Key Points

Analysts expect $0.8160 EPS and $4.51B revenue on May 1

Net income surged 26% but revenue grew only 3.3%, signaling margin expansion

Strong cash flow of $5.22 per share supports 2.46% dividend yield

Meyka AI rates CPA.DE B+, reflecting balanced fundamentals and mature market positioning

CPA.DE (Colgate-Palmolive Company) reports earnings on May 1, 2026. Analysts expect $0.8160 earnings per share and $4.51 billion in revenue. The consumer defensive giant trades at €72.38 with a $58.07 billion market cap. Colgate operates two main segments: Oral, Personal and Home Care, plus Pet Nutrition through Hill’s Science Diet. The company faces mixed signals heading into earnings. Recent performance shows strong net income growth of 26% year-over-year, yet revenue growth remains modest at 3.3%. Investors will scrutinize margin trends and international market performance.

Earnings Estimates and What They Mean

Analysts project $0.8160 earnings per share for this quarter, reflecting steady profitability expectations. Revenue guidance sits at $4.51 billion, suggesting modest top-line growth in a competitive consumer products market. These estimates matter because they signal whether Colgate can maintain pricing power amid inflation pressures.

EPS Expectations

The $0.8160 EPS estimate represents a critical benchmark for investor sentiment. Colgate’s trailing twelve-month EPS stands at $2.25, meaning quarterly estimates suggest normalized earnings. This level indicates the company maintains consistent profitability despite market headwinds. Beat or miss on this metric could trigger significant stock movement.

Revenue Outlook

The $4.51 billion revenue estimate reflects expectations for steady demand across oral care, personal care, and pet nutrition divisions. With trailing revenue per share at $25.33, this quarterly projection aligns with historical run rates. Investors watch revenue closely because it reveals whether Colgate’s brands retain market share against private label competitors.

Colgate’s recent financial trajectory shows diverging signals. Net income surged 26% year-over-year, yet revenue grew only 3.3%, indicating margin expansion rather than volume growth. This pattern suggests successful cost management but raises questions about organic sales momentum.

Profitability Momentum

Operating income jumped 6.1% while EBIT grew 15.5%, demonstrating operational leverage. The company’s 10.5% net profit margin ranks solid for consumer staples. However, this growth came partly from lower share count (down 1.2%), meaning per-share earnings benefited from buybacks alongside operational gains.

Revenue Growth Reality

The 3.3% revenue growth reflects mature market saturation in developed regions. Colgate’s five-year revenue growth per share reached 34.6%, but recent quarters show deceleration. Investors should monitor whether management can reignite organic growth through innovation or emerging market expansion.

Key Metrics and Financial Health

Colgate’s balance sheet reveals a leveraged but stable capital structure. The company carries 158.4x debt-to-equity ratio, reflecting aggressive financial engineering through dividends and buybacks. However, strong cash generation supports this strategy.

Cash Flow Strength

Operating cash flow per share reached $5.22, while free cash flow hit $4.52 per share. The company converts 86.6% of operating cash into free cash flow, indicating efficient capital deployment. This cash generation funds the 2.46% dividend yield, attractive for income investors.

Valuation Metrics

Colgate trades at a 31.9x P/E ratio, elevated for a mature consumer staples company. The 3.33x price-to-sales ratio sits above historical averages, suggesting the market prices in quality and stability. Return on equity of 4.3% appears modest, reflecting the high leverage structure.

What Investors Should Watch

The May 1 earnings call will focus on three critical areas: organic sales growth, margin sustainability, and emerging market performance. Management guidance for the remainder of 2026 matters more than the quarter itself.

Organic Growth Acceleration

Investors need clarity on whether the 3.3% revenue growth represents a floor or a trend. Colgate must demonstrate that pricing actions and product innovation drive volume gains. Any guidance suggesting further deceleration could pressure the stock.

Margin Sustainability

With gross margins at 60.1% and operating margins at 21%, the company has limited room for expansion. Watch for commentary on input costs, freight, and labor inflation. Margin compression would signal pricing power limitations.

Emerging Market Traction

Colgate’s global footprint provides growth optionality. Management commentary on Latin America, Asia-Pacific, and Africa performance will reveal whether international markets offset developed market maturity.

Final Thoughts

Colgate-Palmolive enters earnings season with solid fundamentals but modest growth prospects. The $0.8160 EPS estimate and $4.51 billion revenue guidance reflect market expectations for steady profitability without acceleration. Strong cash generation supports the dividend, while the 31.9x P/E valuation prices in quality and stability. Meyka AI rates CPA.DE with a grade of B+, reflecting balanced fundamentals against sector benchmarks. The key question for May 1: can management reignite organic growth or will Colgate remain a mature, cash-generative dividend play? Investors should focus on forward guidance and emerging market momentum rather than quarterly beats or misses.

FAQs

What EPS and revenue do analysts expect for Colgate’s May 1 earnings?

Analysts project $0.8160 earnings per share and $4.51 billion in revenue, reflecting expectations for steady profitability and modest top-line growth in consumer staples.

How does Colgate’s recent growth compare to earnings estimates?

Recent performance shows 26% net income growth but only 3.3% revenue growth, indicating margin expansion through pricing power rather than volume gains.

What is Meyka AI’s rating for Colgate-Palmolive?

Meyka AI rates CPA.DE with a B+ grade, factoring in S&P 500 comparison, sector performance, financial growth, and analyst consensus. Not guaranteed financial advice.

What should investors watch during the May 1 earnings call?

Focus on organic sales acceleration, margin sustainability, and emerging market performance. Management’s 2026 guidance matters more than quarterly results. Monitor pricing power commentary.

Is Colgate’s valuation expensive compared to peers?

At 31.9x P/E, Colgate trades above consumer staples averages. The 3.33x price-to-sales ratio reflects market pricing for quality, leaving limited upside without growth acceleration.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)